Early Graft Failure



The increasing organ donor shortage in recent years has forced the use of liver allografts with more expanded criteria for selection which are allocated to sicker and more decompensated recipients, resulting in an increase of the number of transplants. Furthermore advance in surgical techniques have allowed the use of partial liver grafts both split and living donor in order to increase to the donor pool. However, this has resulted in novel challenges and particularly graft dysfunction, graft failure, and small for size syndrome (SFSS) have become more important than ever. Clinically, post-liver transplant graft failure is a continuum ranging from an ambiguous and easily reversible graft dysfunction to a complete absence of function and primary non-function. The incidence of graft dysfunction varies from 13 to 27 % and the incidence of primary non-function affects 4–7 % of the deceased donor liver grafts [1–3]. With living donor liver transplantation, cold and warm ischemia times are minimal and donor quality typically excellent and primary non-function is less common with a 3 % incidence reported in the A2ALL study [4]. However, recipients of living donor liver transplants have a higher incidence of SFSS as cause of early graft failure. Early graft failure in both deceased donor and living donor liver transplant recipients has a major impact on the prognosis and clinical outcome after liver transplantation (LT). This chapter will outline the risk factors for early allograft dysfunction and provide a guide to early diagnosis and management strategies of graft failure and SFSS.


International Normalize Ratio Graft Failure Live Donor Liver Transplant Liver Graft Warm Ischemia Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Maring JK, Klompmaker IJ, Zwaveling JH, Kranenburg K, Ten Vergert EM, Slooff MJ. Poor initial graft function after orthotopic liver transplantation: can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantation. Clin Transplant. 1997;11:373–9.PubMedGoogle Scholar
  2. 2.
    Deschenes M, Belle SH, Krom RA, et al. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation. 1998;66:302–10.PubMedCrossRefGoogle Scholar
  3. 3.
    González FX, Rimola A, Grande L, Antolin M, et al. Predictors or early postoperative graft function in human liver transplantation. Hepatology. 1994;20: 565–73.PubMedGoogle Scholar
  4. 4.
    Olthoff KM, Merion RM, Ghobrial RM, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients. Ann Surg. 2005;242(3):314–25.PubMedGoogle Scholar
  5. 5.
    Roloff JS. Disseminated intravascular coagulation and other acquired bleeding disorders. In: Levin DL, Morris FC, editors. Essentials of pediatric intensive care. St. Louis: Quality Medical Publishing; 1990.Google Scholar
  6. 6.
    Rosen HR, Martin P, Goss J, et al. Significance of early aminotransferase elevation after liver transplantation. Transplantation. 1998;65:68–72.PubMedCrossRefGoogle Scholar
  7. 7.
    Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16:943–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Uemura T, Randall HB, Sanchez EQ, Ikegami T, Narasimhan G, McKenna GJ, et al. Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl. 2007;13(2):227–33.PubMedCrossRefGoogle Scholar
  9. 9.
    Henley KS, Lucy MR, Normolle DP, et al. A double blind, randomized, placebo controlled trial of prostaglandin E1 in liver transplantation. Hepatology. 1995;21:366–72.PubMedGoogle Scholar
  10. 10.
    Oldhafer KJ, Bornscheuer A, Fruhauf NR, et al. Rescue hepatectomy for initial graft non-function after liver transplantation. Transplantation. 1999;67:1024–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Demetris AJ, Kelly DM, Eghtesad B, et al. Pathophysiologic observations and histopathologic recognition of the portal hyper perfusion or small for size syndrome. Am J Surg Pathol. 2006;30:986–93.PubMedCrossRefGoogle Scholar
  12. 12.
    Dahm F, Georgiev P, Clavien P. Small for size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005;5:2605–10.PubMedCrossRefGoogle Scholar
  13. 13.
    Tucker ON, Heaton N. The ‘small for size’ liver syndrome. Curr Opin Crit Care. 2005;11:150–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Humar A, Beissel J, Crotteau S, et al. Delayed splenic artery occlusion for treatment of established small for size syndrome after partial liver transplantation. Liver Transpl. 2009;15:163–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of Minnesota Amplatz Children’s HospitalMinneapolisUSA
  2. 2.Department of Transplant HepatologyBaylor University Medical CenterDallasUSA

Personalised recommendations